Publication Information

{'id': 'https://openalex.org/W2473371116', 'doi': None, 'title': '[Phase II study of CGS16949A, a new aromatase inhibitor--a dose finding study].', 'display_name': '[Phase II study of CGS16949A, a new aromatase inhibitor--a dose finding study].', 'publication_year': 1994, 'publication_date': '1994-03-01', 'ids': {'openalex': 'https://openalex.org/W2473371116', 'mag': '2473371116', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/8129387'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/8129387', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5019676153', 'display_name': 'Takeshi Tominaga', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I3020605285', 'display_name': 'Tokyo Metropolitan Komagome Hospital', 'ror': 'https://ror.org/04eqd2f30', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3020605285']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Tominaga T', 'raw_affiliation_strings': ['Dept. of Surgery, Tokyo, Metropolitan Komagome Hospital.'], 'affiliations': [{'raw_affiliation_string': 'Dept. of Surgery, Tokyo, Metropolitan Komagome Hospital.', 'institution_ids': ['https://openalex.org/I3020605285']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103690568', 'display_name': 'Abe O', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Abe O', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085833173', 'display_name': 'Ken Asaishi', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Asaishi K', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085280664', 'display_name': 'Abe R', 'orcid': 'https://orcid.org/0000-0002-5425-524X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Abe R', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078393381', 'display_name': 'Koji Enomoto', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Enomoto K', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078380421', 'display_name': 'Tatehiro Kajiwara', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Kajiwara T', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029687538', 'display_name': 'Mihoko Yoshida', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Yoshida M', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035193197', 'display_name': 'Takahito Wada', 'orcid': 'https://orcid.org/0000-0002-9540-1354'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Wada T', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5021874441', 'display_name': 'Yoshiki Nomura', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Nomura Y', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.3423, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 53, 'max': 61}, 'biblio': {'volume': '21', 'issue': '4', 'first_page': '465', 'last_page': '75'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10756', 'display_name': 'Mechanisms of Estrogen Receptor Signaling', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10756', 'display_name': 'Mechanisms of Estrogen Receptor Signaling', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12829', 'display_name': 'Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer', 'score': 0.9744, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11752', 'display_name': 'Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment', 'score': 0.9661, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/group-b', 'display_name': 'Group B', 'score': 0.550904}, {'id': 'https://openalex.org/keywords/aromatase-inhibitors', 'display_name': 'Aromatase Inhibitors', 'score': 0.509978}, {'id': 'https://openalex.org/keywords/group-a', 'display_name': 'Group A', 'score': 0.4818705}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6946602}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5557314}, {'id': 'https://openalex.org/C2777785397', 'wikidata': 'https://www.wikidata.org/wiki/Q492194', 'display_name': 'Group B', 'level': 2, 'score': 0.550904}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.5280524}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.5251783}, {'id': 'https://openalex.org/C2780678043', 'wikidata': 'https://www.wikidata.org/wiki/Q743241', 'display_name': 'Group A', 'level': 2, 'score': 0.4818705}, {'id': 'https://openalex.org/C61511704', 'wikidata': 'https://www.wikidata.org/wiki/Q1671857', 'display_name': 'Incidence (geometry)', 'level': 2, 'score': 0.432756}, {'id': 'https://openalex.org/C120665830', 'wikidata': 'https://www.wikidata.org/wiki/Q14620', 'display_name': 'Optics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D017316', 'descriptor_name': 'Fadrozole', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004958', 'descriptor_name': 'Estradiol', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D004958', 'descriptor_name': 'Estradiol', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017316', 'descriptor_name': 'Fadrozole', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017316', 'descriptor_name': 'Fadrozole', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D017316', 'descriptor_name': 'Fadrozole', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009325', 'descriptor_name': 'Nausea', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009325', 'descriptor_name': 'Nausea', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D017698', 'descriptor_name': 'Postmenopause', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014839', 'descriptor_name': 'Vomiting', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014839', 'descriptor_name': 'Vomiting', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/8129387', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.85, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W34952629', 'https://openalex.org/W3032427557', 'https://openalex.org/W3032164456', 'https://openalex.org/W2386212801', 'https://openalex.org/W2382704688', 'https://openalex.org/W2372511274', 'https://openalex.org/W2358181595', 'https://openalex.org/W2353861641', 'https://openalex.org/W2107321100', 'https://openalex.org/W1979076702'], 'abstract_inverted_index': {'A': [0], 'dose': [1, 23, 51, 300], 'finding': [2], 'phase': [3], 'II': [4], 'study': [5], 'of': [6, 24, 108, 130, 159, 171, 187, 208, 213, 228, 252, 268], 'a': [7], 'novel': [8], 'aromatase': [9], 'inhibitor': [10], 'CGS16949A': [11, 41, 280], 'was': [12, 42, 89, 110, 132, 263, 272, 295], 'performed': [13], 'in': [14, 58, 67, 94, 116, 140, 152, 178, 195, 219, 224, 257, 277, 287, 301], 'postmenopausal': [15, 288], 'patients': [16, 151, 289], 'with': [17, 259, 290], 'advanced': [18, 291], 'breast': [19, 292], 'cancer.': [20, 293], 'The': [21, 54, 185], 'daily': [22], '1': [25, 68, 117, 141, 196], 'mg': [26, 28, 31, 33, 37, 39, 72, 78, 85, 120, 123, 144, 147, 182, 199, 202], '(0.5': [27], 'b.i.d.),': [29], '2': [30, 74, 119, 143, 179, 198, 230, 306], '(1': [32, 71], 'b.i.d.)': [34, 40], 'or': [35, 48, 165], '4': [36, 81, 122, 146, 181, 201, 232], '(2': [38, 77], 'administered': [43], 'orally': [44], 'for': [45], '8': [46], 'weeks': [47], 'more': [49], 'on': [50], 'escalation': [52], 'schedule.': [53], 'response': [55, 96, 131], 'rates': [56, 97], '(CR+PR)': [57], 'the': [59, 95, 99, 106, 127, 225, 253, 266, 298], 'evaluable': [60], 'cases': [61], 'were': [62, 173, 190, 212, 217], '13.6%,': [63], '22.0%': [64], 'and': [65, 80, 113, 121, 126, 137, 145, 175, 180, 193, 200, 205, 222, 231, 234, 262, 284], '13.3%': [66], 'mg/day': [69, 75, 82], 'group': [70, 76, 83, 155, 183, 203], 'group),': [73, 86], 'group)': [79], '(4': [84], 'respectively.': [87, 149, 184], 'There': [88], 'no': [90, 235], 'statistically': [91], 'significant': [92], 'difference': [93], 'among': [98], 'three': [100], 'treatment': [101, 154, 254], 'groups.': [102], 'Median': [103, 169], 'time': [104], 'to': [105, 241], 'onset': [107], 'PR': [109], '99,': [111], '113': [112], '114': [114], 'days': [115, 136, 139, 177], 'mg,': [118, 142, 197, 233], 'group,': [124, 148], 'respectively,': [125, 204], 'median': [128], 'duration': [129], '276': [133], 'days,': [134], '391': [135], '277': [138], 'Five': [150], 'each': [153], 'showed': [156, 281], 'prolonged': [157], 'stabilization': [158, 172], 'disease': [160], '("long': [161], 'NC",': [162], 'lasting': [163], '>': [164], '=': [166], '6': [167], 'months).': [168], 'durations': [170], '223': [174], '241': [176], 'incidence': [186], 'adverse': [188], 'effects': [189], '11.9%,': [191], '7.5%': [192], '13.0%': [194], '30': [206], 'out': [207], '33': [209], 'symptoms': [210, 239], '(90.9%)': [211], 'mild.': [214], 'Laboratory': [215], 'abnormalities': [216], 'observed': [218], '12.2%,': [220], '22.9%': [221], '23.8%': [223], 'respective': [226], 'groups': [227], '1,': [229], 'patient': [236], 'experienced': [237], 'clinical': [238, 302], 'related': [240], 'these': [242], 'changes.': [243], 'Plasma': [244, 270], 'estradiol': [245], 'concentration': [246], 'at': [247], 'one': [248], 'month': [249], 'after': [250], 'initiation': [251], 'decreased': [255], 'significantly': [256], 'comparison': [258], 'pretreatment': [260], 'levels,': [261], 'slightly': [264], 'exceeding': [265], 'limit': [267], 'detection.': [269], 'cortisol': [271], 'not': [273], 'changed.': [274], 'As': [275], 'shown': [276], 'this': [278], 'results,': [279], 'sufficient': [282], 'efficacy': [283], 'good': [285], 'tolerability': [286], 'It': [294], 'considered': [296], 'that': [297], 'optimal': [299], 'use': [303], 'judged': [304], 'as': [305], 'mg/day.': [307]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2473371116', 'counts_by_year': [], 'updated_date': '2024-09-15T18:12:06.016447', 'created_date': '2016-07-22'}